These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36260281)

  • 1. Investigation of the immune escape mechanism of Treponema pallidum.
    Tang Y; Zhou Y; He B; Cao T; Zhou X; Ning L; Chen E; Li Y; Xie X; Peng B; Hu Y; Liu S
    Infection; 2023 Apr; 51(2):305-321. PubMed ID: 36260281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Modeling of the Treponema pallidum Outer Membrane Protein Repertoire: a Road Map for Deconvolution of Syphilis Pathogenesis and Development of a Syphilis Vaccine.
    Hawley KL; Montezuma-Rusca JM; Delgado KN; Singh N; Uversky VN; Caimano MJ; Radolf JD; Luthra A
    J Bacteriol; 2021 Jul; 203(15):e0008221. PubMed ID: 33972353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
    Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
    Front Immunol; 2021; 12():759474. PubMed ID: 34899710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological basis for syphilis.
    Lafond RE; Lukehart SA
    Clin Microbiol Rev; 2006 Jan; 19(1):29-49. PubMed ID: 16418521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Overview of
    Wu S; Luo L; Ye F; Wang Y; Li D
    Curr Protein Pept Sci; 2024; 25(8):604-612. PubMed ID: 38661035
    [No Abstract]   [Full Text] [Related]  

  • 6. An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach.
    Kumar Jaiswal A; Tiwari S; Jamal SB; Barh D; Azevedo V; Soares SC
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the invasion process and immune-protective evaluation of Tp0971, a membrane lipoprotein from
    Zhang X; Duan J; Wang Y; Xie B; Zhou J; Zhao S; Yin W; Liu P; Zhao F
    Microbiol Spectr; 2023 Dec; 11(6):e0004723. PubMed ID: 37855609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
    Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
    BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
    Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
    Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
    Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notes on syphilis vaccine development.
    Kojima N; Konda KA; Klausner JD
    Front Immunol; 2022; 13():952284. PubMed ID: 35967432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of Full-Length TprK Diversity in Treponema pallidum subsp.
    Addetia A; Lin MJ; Phung Q; Xie H; Huang ML; Ciccarese G; Dal Conte I; Cusini M; Drago F; Giacani L; Greninger AL
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.
    Norris SJ
    Microbiol Rev; 1993 Sep; 57(3):750-79. PubMed ID: 8246847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
    Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
    Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treponema pallidum outer membrane proteins: current status and prospects.
    Chen J; Huang J; Liu Z; Xie Y
    Pathog Dis; 2022 Sep; 80(1):. PubMed ID: 35869970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term
    Edmondson DG; Hu B; Norris SJ
    mBio; 2018 Jun; 9(3):. PubMed ID: 29946052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards an effective syphilis vaccine: the past, present and future.
    Cullen PA; Cameron CE
    Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syphilis vaccine: challenges, controversies and opportunities.
    Ávila-Nieto C; Pedreño-López N; Mitjà O; Clotet B; Blanco J; Carrillo J
    Front Immunol; 2023; 14():1126170. PubMed ID: 37090699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
    Tomson FL; Conley PG; Norgard MV; Hagman KE
    Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.